<DOC>
	<DOC>NCT00232492</DOC>
	<brief_summary>The purpose of the study is to determine whether equal subanesthetic doses of racemic ketamine is equally effective on females and males after surgical removal of third molars</brief_summary>
	<brief_title>Ketamine on Acute Pain in Females and Males</brief_title>
	<detailed_description>Ketamine is assumed to be a NMDA receptor antagonist which provides analgesia from acute postoperative pain(and other types of pain) subanesthetic doses. Gender differences in ketamine analgesia are not known. This placebo-controlled,randomised, parallel group study investigates the analgesic dose-response effect of ketamine in subanesthetic doses in female and male patients following surgical removal of third molars. Comparisons: Placebo and ketamine in females and males.</detailed_description>
	<mesh_term>Tooth Diseases</mesh_term>
	<mesh_term>Tooth, Impacted</mesh_term>
	<mesh_term>Stomatognathic Diseases</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Indication for removal of third molar Between 20 and 30 years of age ASA Class 1 Psychiatric family (father/mother) or own anamnestic history Hypersensitivity towards NSAIDS or other rescue analgesics Verified or suspected pregnancy Lactating females Surgery lasting over 60 min</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Wisdom</keyword>
	<keyword>Tooth</keyword>
	<keyword>Teeth</keyword>
	<keyword>Third</keyword>
	<keyword>Molar</keyword>
</DOC>